Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation.
Dr. Matthew R. Wilson, Department of Haematology, 3rd Floor Macewan Building, Glasgow Royal Infirmary, Castle Street, Glasgow G4 0SF, UK, Tel.: +44 141 211 4000, E-mail: matthewwilson1@nhs.net.
Matthew R
MR
Wilson
Ruwan
R
Parakramawansha
Terence J
TJ
Quinn
Robert C
RC
Tait
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin